Utilization of Liquid Chromatography Mass Spectrometry Analyses to Identify LKB1–APC Interaction in Modulating Wnt/β-Catenin Pathway of Lung Cancer Cells
Authors:
- Chang-Chun HsiaoCHChang-Chun Hsiao
- Shin-Yi ChenSCShin-Yi Chen
- Ching-Chieh WengCWChing-Chieh Weng
- Tzu-Lei KuoTKTzu-Lei Kuo
- Deng-Chyang WuDWDeng-Chyang Wu
- Wen-Chun HungWHWen-Chun Hung
- Kuang-Hung ChengKCKuang-Hung Cheng
- 14 April 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 12 (4) , 622-635
Abstract
STK11/LKB1, a serine/threonine protein kinase and tumor suppressor, is a key upstream kinase of adenine monophosphate-activated protein kinase, which is a kinase involved in controlling cell polarity and maintaining cellular energy homeostasis. LKB1 is mutated in a significant number of Peutz–Jeghers syndrome (PJS) cases and sporadic cancers, and is most frequently mutated in lung adenocarcinomas; however, little is known about how LKB1 is involved in lung cancer progression. In this study, immunoprecipitation-HPLC tandem mass spectrometry (IP-LC-MS/MS) was performed to identify novel proteins interacting with LKB1 in lung cancer. Interestingly, many LKB1-interacting proteins acquired from the LC-MS/MS approach were mapped, using MetaCore pathway analysis, to the cystic fibrosis transmembrane conductance regulator activation pathway. Moreover, it was determined that LKB1 directly interacts with APC, and this LKB1–APC interaction was further confirmed by reverse immunoprecipitation assays, but GSK3β was dispensable for the association of LKB1 and APC. Importantly, LKB1 binds to APC to suppress the Wnt/β-catenin signaling pathway, which is known to be involved in cell proliferation and migration. Subsequent analysis of the downstream targets of the Wnt/TCF pathway led to the identification of several Wnt-regulated genes, such as CD44, COX-2, survivin, and c-Myc, whose expression levels are downregulated by LKB1. In summary, these results demonstrate that LKB1 regulates the Wnt pathway through a direct interaction with APC to suppress the tumorigenic/metastatic potential of lung tumors. Implications: LKB1 status influences the molecular circuitry (Wnt/β-catenin pathway), cellular biology, and may serve as a potential therapeutic node in genetically defined subsets of lung cancer. Mol Cancer Res; 12(4); 622–35. ©2014 AACR.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung TumorsCancer Cell, 2010
- Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2009
- Mutated K‐rasAsp12 promotes tumourigenesis in ApcMin mice more in the large than the small intestines, with synergistic effects between K‐ras and Wnt pathwaysInternational Journal of Experimental Pathology, 2009
- A gene-alteration profile of human lung cancer cell linesHuman Mutation, 2009
- Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsBritish Journal of Cancer, 2008
- LKB1 modulates lung cancer differentiation and metastasisNature, 2007
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerGenes & Development, 2006
- MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasmThe EMBO Journal, 2003
- Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formationOncogene, 2002
- Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinaseNature Genetics, 1998